Efficacy and Safety of Tralokinumab in Adolescents With Moderate to Severe Atopic Dermatitis: The Phase 3 ECZTRA 6 Randomized Clinical Trial - PubMed

ClinicalTrials.gov Identifier: NCT03526861.
pubmed.ncbi.nlm.nih.gov pubmed.ncbi.nlm.nih.gov